The binding of chemokine CCL17 to its receptor CCR4 was shown to enhance MMP-13 expression in bladder cancer through the activation of extracellular signal-regulated kinase (ERK) 1/2 signalling [62], and in colorectal cancer through the activation of ERK/NF-κB signalling [63]. Here, MMP13 is linked to urinary bladder cancer.